Venatorx Pharmaceuticals: NEW Antibiotics to Treat Drug-Resistant Gram-Negative Bacteria Including Public Health Pathogens
Contract Overview
Contract Amount: $26,449,853 ($26.4M)
Contractor: Basilea Pharmaceutica International Ltd, Allschwil
Awarding Agency: Department of Health and Human Services
Start Date: 2023-09-15
End Date: 2026-12-31
Contract Duration: 1,203 days
Daily Burn Rate: $22.0K/day
Official Description: VENATORX PHARMACEUTICALS: NEW ANTIBIOTICS TO TREAT DRUG-RESISTANT GRAM-NEGATIVE BACTERIA INCLUDING PUBLIC HEALTH PATHOGENS.
Place of Performance
Location: Pennsylvania, 19355